Article Text

0274: Nci 5886, a Phase II Study of Erlotinib, Carboplatin and Paclitaxel As First-Line Treatment of Ovarian Cancer

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.